The US government by itself spends upwards of $7 billion a year on cancer research. Add in worldwide government spending, private pharma R&D, charities and more and that number is likely in the $100B-130B range. Per year. Anthropic meanwhile has raised $130B in its lifetime and another $80B at IPO, and earns $80B/yr in revenue.
I'd say the allocation problem is on the cancer side.
> The US government by itself spends upwards of $7 billion a year on cancer research.
Right. On what is probably the most significant solvable health issue of our age.
Compare this to what, $3 trillion parked in the stock of an ad tech company (Google) and now another $2 trillion betting on some wishy-washy benefits of AI (maybe it will cure cancer too? the founder said so).
I don't think that central planning is a good alternative, but I think we should talk about this, because capitalism evidently doesn't produce a particularly efficient allocation of resources either. As it turns out, you can have massive industries that do relatively little for mankind but are very attractive to investors.